• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Botox All Good With High Price Tag On Amgen Drug

anonymous

Guest
mgen will charge $6,900 a year for a new drug that can spare migraine sufferers a few headaches each month, a price that comes in well below Wall Street expectations as the company hopes to avoid the payer backlash that has hamstrung recent drug launches.
 




First to market, first to profits. Amgen will make a killing on this drug and watch AGN's acute pill literally flop! Another sign of stupidity with management! Saunders is burning this company to the ground!
 




I cannot wait for Amgen to kick some MF ass! Neuroscience has been lead by narcissistic white men for decades. Your time is up. I want a front row seat for this show.